Carbonic anhydrase II in complex with carboxylic acid-based inhibitors

Acta Crystallogr F Struct Biol Commun. 2019 Mar 1;75(Pt 3):166-170. doi: 10.1107/S2053230X18018344. Epub 2019 Feb 20.

Abstract

Carbonic anhydrases (CAs) are molecular targets in various diseases. While many sulfonamide-based drugs are in clinical use, CA inhibitor design is moving towards the incorporation of alternative zinc-binding groups, such as carboxylic acids, to promote CA isoform-specific inhibition. Here, X-ray crystal structures of CA II in complex with nicotinic acid and ferulic acid determined to 1.70 and 1.50 Å resolution, respectively, are reported. Furthermore, the structures of these two compounds are superimposed with previously determined structures to compare the mechanisms of inhibition and the properties of carboxylic acid-based CA inhibitors. This study examines an important class of alternative, non-sulfonamide-based CA inhibitors and provides insight to facilitate the structure-guided design of CA isoform-specific inhibitors.

Keywords: carbonic anhydrase II; carboxylic acids; structure-guided drug design.

MeSH terms

  • Carbonic Anhydrase II / chemistry
  • Carbonic Anhydrase II / metabolism*
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / metabolism*
  • Carboxylic Acids / chemistry*
  • Crystallography, X-Ray
  • Drug Design
  • Protein Isoforms / chemistry
  • Protein Isoforms / metabolism*
  • Structure-Activity Relationship
  • Sulfonamides / chemistry

Substances

  • Carbonic Anhydrase Inhibitors
  • Carboxylic Acids
  • Protein Isoforms
  • Sulfonamides
  • Carbonic Anhydrase II